Hogar y Estilo de Vida
5 hábitos para añadir años a tu vida
Ver más
Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 05.001.024 | Ado-Trastuzumab Emtansine (Trastuzumab-Dm1) For Treatment Of Her2-Positive Malignancies | Aug 19, 2024 | Aug 20, 2025 | Ado-trastuzumab emtansine, also known as trastuzumab-dm1 (t-dm1), is an antibody-drug conjugate that links... | Ver |
| 05.001.026 | Pertuzumab For Treatment Of Malignancies | Nov 12, 2024 | Nov 20, 2025 | Pertuzumab (perjeta), a monoclonal antibody, is a human epidermal growth factor receptor 2 (her2) antagonist.... | Ver |
| 05.001.028 | Treatment For Spinal Muscular Atrophy | Apr 19, 2024 | Apr 20, 2025 | Spinal muscular atrophy is an inherited disorder caused by homozygous deletions or variants in the smn1 gene.... | Ver |
| 05.001.029 | Nononcologic Uses Of Rituximab | Nov 14, 2024 | Nov 20, 2025 | ... | Ver |
| 05.001.030 | Testosterone Replacement Therapies | Aug 13, 2024 | Aug 20, 2025 | Testosterone replacement therapy is the primary treatment for androgen deficiency in men. testosterone... | Ver |
| 05.001.031 | Treatment For Duchenne Muscular Dystrophy | Sep 24, 2024 | Jun 20, 2025 | Duchenne muscular dystrophy is an inherited disorder that results in progressive muscle weakness and loss of... | Ver |
| 05.001.032 | Buprenorphine Implant For Treatment Of Opioid Dependence | Oct 18, 2022 | Policy Archived | Buprenorphine is a partial μ-opioid agonist used to treat patients with an opioid addiction. administered... | Ver |
| 05.001.033 | Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adult Patients | Jan 14, 2025 | Jan 20, 2026 | Hereditary transthyretin-mediated amyloidosis (hattr) is a rare, progressive, and fatal autosomal dominant... | Ver |
| 05.001.034 | Tropomyosin Receptor Kinase Inhibitors For Locally Advanced Or Metastatic Solid Tumors Harboring An Ntrk Gene Fusion | Apr 19, 2024 | Policy Archived | The tropomyosin receptor kinase (trk)-receptor family is encoded by the 3 neurotrophic receptor tyrosine... | Ver |
| 05.001.035 | Monoclonal Antibody Therapies For Migraine and Cluster Headache | Jan 15, 2025 | Jan 20, 2026 | Migraine is a headache disorder characterized by recurrent moderate to severe headaches with associated... | Ver |
| 05.001.036 | Brexanolone For Postpartum Depression | Sep 10, 2024 | Sep 20, 2025 | Postpartum depression (ppd) is a serious and debilitating condition that is characterized by a major... | Ver |
| 05.001.037 | Medical Cannabis For The Treatment Of Pain And Spasticity | Sep 07, 2023 | Policy Archived | Cannabis describes organic products (eg, cannabinoids, marijuana, hemp) that are derived from the cannabis... | Ver |
| 05.001.038 | Erythropoiesis-Stimulating Agents | Nov 11, 2024 | Nov 20, 2025 | Endogenous erythropoietin is a glycoprotein hematopoietic growth factor that regulates hemoglobin levels in... | Ver |
| 05.001.039 | Intravenous Antibiotic Therapy And Associated Diagnostic Testing For Lyme Disease | Nov 22, 2024 | Nov 20, 2025 | Lyme disease is a multisystem inflammatory disease caused by the spirochete borrelia burgdorferi and... | Ver |
| 05.001.040 | Repository Corticotropin Injection | Nov 22, 2024 | Nov 20, 2025 | Repository corticotropin injection is a preparation of the natural form of adrenocorticotropic hormone... | Ver |
| 05.001.041 | Injectable Clostridial Collagenase For Fibroproliferative Disorders | Apr 17, 2024 | Apr 20, 2025 | Clostridial collagenase is a bacterial collagenase, derived from clostridium histolyticum, which has been... | Ver |
| 05.001.042 | Esketamine Nasal Spray For Treatment-Resistant Depression | Nov 12, 2024 | Nov 20, 2025 | Esketamine is the s-isomer of racemic ketamine. esketamine targets the n-methyl-d-aspartate receptor, an... | Ver |
| 05.001.043 | Hematopoietic Colony-Stimulating Factors (Csfs) | Oct 24, 2024 | Oct 20, 2025 | There are several brands of short-acting colony stimulating factor (csf) products on the market, including... | Ver |
| 05.001.044 | (Polatuzumab Vedotin-Piiq) Polivy | Oct 24, 2024 | Oct 20, 2025 | Polivy is a cd79b-directed antibody–drug conjugate indicated in combination with bendamustine and a... | Ver |
| 05.001.045 | Lumasiran For Primary Hyperoxaluria Type 1 | Aug 09, 2024 | Aug 20, 2025 | Primary hyperoxalurias are a group of rare genetic diseases. there are 3 subtypes each resulting in the... | Ver |
